CEO Of Malaysia’s BiotechCorp Says Country To Be Global Player
This article was originally published in PharmAsia News
The head of Malaysian Biotechnology Corp. says his country is on a path toward becoming a significant global player by 2018. CEO Datuk Iskandar Mizal Mahmood said at BioMalaysia 2008 in Kuala Lumpur when talking about the services of his agency, which serves as government promoter of biotechnology industry in the Malaysia, more money needs to be put into high-quality training of Malaysians who will be needed to do the work. Officers of foreign partners confirmed Malaysia's biotech pace, one from India suggesting the Malaysian government should hold down the personal income tax levied on the foreign professionals who will be needed to provide that training. (Click here for more
You may also be interested in...
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.
Early Research Suggests Wearables Can Spot Early Signs Of COVID-19; Fitbit Receives $2.5m Army Award
A consortium of researchers, including Fitbit, are developing algorithms to spot COVID-19 before people become ill.